These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

701 related items for PubMed ID: 22183160

  • 1. Ruthenium(II)/(III) complexes of 4-hydroxy-pyridine-2,6-dicarboxylic acid with PPh3/AsPh3 as co-ligand: impact of oxidation state and co-ligands on anticancer activity in vitro.
    Kamatchi TS, Chitrapriya N, Lee H, Fronczek CF, Fronczek FR, Natarajan K.
    Dalton Trans; 2012 Feb 21; 41(7):2066-77. PubMed ID: 22183160
    [Abstract] [Full Text] [Related]

  • 2. Ruthenium(III) S-methylisothiosemicarbazone Schiff base complexes bearing PPh3/AsPh3 coligand: synthesis, structure and biological investigations, including antioxidant, DNA and protein interaction, and in vitro anticancer activities.
    Prakash G, Manikandan R, Viswanathamurthi P, Velmurugan K, Nandhakumar R.
    J Photochem Photobiol B; 2014 Sep 05; 138():63-74. PubMed ID: 24911273
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Synthesis, DNA-binding, photocleavage, cytotoxicity and antioxidant activity of ruthenium (II) polypyridyl complexes.
    Liu YJ, Zeng CH, Huang HL, He LX, Wu FH.
    Eur J Med Chem; 2010 Feb 05; 45(2):564-71. PubMed ID: 19932529
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Synthesis of ruthenium(II) complexes and characterization of their cytotoxicity in vitro, apoptosis, DNA-binding and antioxidant activity.
    Liu YJ, Zeng CH, Liang ZH, Yao JH, Huang HL, Li ZZ, Wu FH.
    Eur J Med Chem; 2010 Jul 05; 45(7):3087-95. PubMed ID: 20417586
    [Abstract] [Full Text] [Related]

  • 9. Copper(I) and nickel(II) complexes with 1:1 vs. 1:2 coordination of ferrocenyl hydrazone ligands: do the geometry and composition of complexes affect DNA binding/cleavage, protein binding, antioxidant and cytotoxic activities?
    Krishnamoorthy P, Sathyadevi P, Butorac RR, Cowley AH, Bhuvanesh NS, Dharmaraj N.
    Dalton Trans; 2012 Apr 21; 41(15):4423-36. PubMed ID: 22344370
    [Abstract] [Full Text] [Related]

  • 10. Study of ruthenium(II) complexes with anticancer drugs as ligands. Design of metal-based phototherapeutic agents.
    Cini R, Tamasi G, Defazio S, Corsini M, Zanello P, Messori L, Marcon G, Piccioli F, Orioli P.
    Inorg Chem; 2003 Dec 01; 42(24):8038-52. PubMed ID: 14632524
    [Abstract] [Full Text] [Related]

  • 11. Ruthenium (II) nitrofurylsemicarbazone complexes: new DNA binding agents.
    Cabrera E, Cerecetto H, González M, Gambino D, Noblia P, Otero L, Parajón-Costa B, Anzellotti A, Sánchez-Delgado R, Azqueta A, López de Ceráin A, Monge A.
    Eur J Med Chem; 2004 Apr 01; 39(4):377-82. PubMed ID: 15072846
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A novel water soluble ligand bridged cobalt(II) coordination polymer of 2-oxo-1,2-dihydroquinoline-3-carbaldehyde (isonicotinic) hydrazone: evaluation of the DNA binding, protein interaction, radical scavenging and anticancer activity.
    Raja DS, Bhuvanesh NS, Natarajan K.
    Dalton Trans; 2012 Apr 21; 41(15):4365-77. PubMed ID: 22354161
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mixed ligand palladium(II) complexes of 6-methoxy-2-oxo-1,2-dihydroquinoline-3-carbaldehyde 4N-substituted thiosemicarbazones with triphenylphosphine co-ligand: synthesis, crystal structure and biological properties.
    Ramachandran E, Senthil Raja D, Bhuvanesh NS, Natarajan K.
    Dalton Trans; 2012 Nov 21; 41(43):13308-23. PubMed ID: 22864662
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Tuning of redox potentials for the design of ruthenium anticancer drugs -- an electrochemical study of [trans-RuCl(4)L(DMSO)](-) and [trans-RuCl(4)L(2)](-) complexes, where L = imidazole, 1,2,4-triazole, indazole.
    Reisner E, Arion VB, Guedes da Silva MF, Lichtenecker R, Eichinger A, Keppler BK, Kukushkin VY, Pombeiro AJ.
    Inorg Chem; 2004 Nov 01; 43(22):7083-93. PubMed ID: 15500346
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.